The average one-year price target for Ocugen (NasdaqCM:OCGN) has been revised to $8.36 / share. This is an increase of 26.15% from the prior estimate of $6.63 dated September 27, 2025. The price ...
Investors might want to bet on Ocugen (OCGN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...
) has been revised to $11.37 / share. This is an increase of 11.43% from the prior estimate of $10.20 dated March 25, 2026. The price target is an average of many targets provided by analysts. The ...
Ocugen OCGN is advancing a late-stage ophthalmology pipeline built around one-time gene therapies for retinal diseases with ...
Ocugen, Inc. (NASDAQ:OCGN) is one of the 11 Best High Volume Penny Stocks to Buy Now. On March 17, 2026, Canaccord initiated coverage of Ocugen, Inc. (NASDAQ:OCGN) with a Buy rating and a $12 price ...
Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter Ocugen ( (OCGN)) has shared an update. Ocugen, Inc. reported that Chief Accounting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results